Shashank Tummala
Mysore, KA, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
RAGE receptor targeted bioconjuguate lipid nanoparticles of diallyl disulfide for improved apoptotic activity in triple negative breast cancer: in vitro studies.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: April 19, 2017
Oxaliplatin immunohybrid nanoparticles in vitro synergistic suppression evaluation in treatment of colorectal cancer.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: March 03, 2016
Formulation and optimization of oxaliplatin immuno-nanoparticles using Box-Behnken design and cytotoxicity assessment for synergistic and receptor-mediated targeting in the treatment of colorectal cancer.
Journal: Artificial cells, nanomedicine, and biotechnology
Published: December 25, 2015
5-Fluorouracil enteric-coated nanoparticles for improved apoptotic activity and therapeutic index in treating colorectal cancer.
Journal: Drug delivery
Published: December 05, 2015
Lipid-based nanocarriers for breast cancer treatment - comprehensive review.
Journal: Drug delivery
Published: October 03, 2015
Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors.
Journal: Drug delivery
Published: September 18, 2015
Formulation and characterization of 5-Fluorouracil enteric coated nanoparticles for sustained and localized release in treating colorectal cancer.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: September 25, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026